Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics - Halperin,J.L.; Executive Steering Committee,null.; SPORTIF III and V Study Investigators,null. (Am Heart J, 2003)